DSCPX | FTHFX | DSCPX / FTHFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 13 years | - |
Gain YTD | 5.478 | 13.441 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 1000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.02B | 10.6B | 10% |
Annual Yield % from dividends | 0.58 | 0.95 | 61% |
Returns for 1 year | 8.60 | 14.69 | 59% |
Returns for 3 years | 3.13 | 32.34 | 10% |
Returns for 5 years | 24.44 | 78.82 | 31% |
Returns for 10 years | N/A | 114.19 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 62.33 | 0.78 | +1.27% |
Virtus LifeSci Biotech Products ETF | |||
PWV | 57.84 | -0.24 | -0.41% |
Invesco Large Cap Value ETF | |||
AVUV | 100.03 | -1.42 | -1.40% |
Avantis US Small Cap Value ETF | |||
TSME | 38.33 | -0.58 | -1.49% |
Thrivent Small-Mid Cap ESG ETF | |||
AMUB | 18.50 | -0.56 | -2.96% |
UBS ETRACS Alerian MLP ETN Series B |